{"transactions":[{"id":4203099,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-22T21:30:29.000Z","date":"2017-09-20","kind":"exercise","acquired":false,"shares":14230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option are fully vested."}],"balance_after":5000,"derivative":{"exercise_price":0.63,"expiration_date":"2021-02-16","underlying":"Common Stock","underlying_shares":14230},"source":{"system":"sec-edgar","filing":"0001638599-17-000948","document":"doc4_4980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000948/doc4_4980.xml","form_type":"4"}},{"id":4203098,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-22T21:30:29.000Z","date":"2017-09-20","kind":"exercise","acquired":false,"shares":2194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.63,"expiration_date":"2020-09-06","underlying":"Common Stock","underlying_shares":2194},"source":{"system":"sec-edgar","filing":"0001638599-17-000948","document":"doc4_4980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000948/doc4_4980.xml","form_type":"4"}},{"id":4203097,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-09-22T21:30:29.000Z","date":"2017-09-20","kind":"sale","acquired":false,"shares":14230,"price":20,"value":284600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001638599-17-000948","document":"doc4_4980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000948/doc4_4980.xml","form_type":"4"}},{"id":4203096,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-09-22T21:30:29.000Z","date":"2017-09-20","kind":"exercise","acquired":true,"shares":14230,"price":0.63,"value":8964.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":14230,"source":{"system":"sec-edgar","filing":"0001638599-17-000948","document":"doc4_4980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000948/doc4_4980.xml","form_type":"4"}},{"id":4203095,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-09-22T21:30:29.000Z","date":"2017-09-20","kind":"sale","acquired":false,"shares":2194,"price":20,"value":43880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001638599-17-000948","document":"doc4_4980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000948/doc4_4980.xml","form_type":"4"}},{"id":4203094,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-09-22T21:30:29.000Z","date":"2017-09-20","kind":"exercise","acquired":true,"shares":2194,"price":0.63,"value":1382.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":2194,"source":{"system":"sec-edgar","filing":"0001638599-17-000948","document":"doc4_4980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000948/doc4_4980.xml","form_type":"4"}},{"id":4259042,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-11T20:46:38.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on June 16, 2018.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":19.33,"expiration_date":"2027-07-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001638599-17-000704","document":"doc4_4848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000704/doc4_4848.xml","form_type":"4"}},{"id":4264215,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-07-05T20:06:06.000Z","date":"2017-06-30","kind":"exercise","acquired":false,"shares":7420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares underlying this option are fully vested."}],"balance_after":2194,"derivative":{"exercise_price":0.63,"expiration_date":"2020-09-06","underlying":"Common Stock","underlying_shares":7420},"source":{"system":"sec-edgar","filing":"0001638599-17-000675","document":"doc4_4830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000675/doc4_4830.xml","form_type":"4"}},{"id":4264214,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-05T20:06:06.000Z","date":"2017-06-30","kind":"sale","acquired":false,"shares":7420,"price":20.0007,"value":148405.194,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001638599-17-000675","document":"doc4_4830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000675/doc4_4830.xml","form_type":"4"}},{"id":4264213,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-05T20:06:06.000Z","date":"2017-06-30","kind":"exercise","acquired":true,"shares":7420,"price":0.63,"value":4674.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":7420,"source":{"system":"sec-edgar","filing":"0001638599-17-000675","document":"doc4_4830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000675/doc4_4830.xml","form_type":"4"}},{"id":4269246,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-30T20:33:56.000Z","date":"2017-06-29","kind":"exercise","acquired":false,"shares":5770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares underlying this option are fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":9614,"derivative":{"exercise_price":0.63,"expiration_date":"2020-09-06","underlying":"Common Stock","underlying_shares":5770},"source":{"system":"sec-edgar","filing":"0001638599-17-000668","document":"doc4_4828.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000668/doc4_4828.xml","form_type":"4"}},{"id":4269245,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-30T20:33:56.000Z","date":"2017-06-29","kind":"exercise","acquired":false,"shares":3846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares underlying this option are fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.47,"expiration_date":"2019-09-19","underlying":"Common Stock","underlying_shares":3846},"source":{"system":"sec-edgar","filing":"0001638599-17-000668","document":"doc4_4828.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000668/doc4_4828.xml","form_type":"4"}},{"id":4269244,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-30T20:33:56.000Z","date":"2017-06-29","kind":"sale","acquired":false,"shares":36,"price":20,"value":720.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 36 shares sold were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001638599-17-000668","document":"doc4_4828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000668/doc4_4828.xml","form_type":"4"}},{"id":4269243,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-30T20:33:56.000Z","date":"2017-06-29","kind":"sale","acquired":false,"shares":9616,"price":20.0002,"value":192321.9232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive.  The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the set forth herein."}],"balance_after":36,"source":{"system":"sec-edgar","filing":"0001638599-17-000668","document":"doc4_4828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000668/doc4_4828.xml","form_type":"4"}},{"id":4269242,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-30T20:33:56.000Z","date":"2017-06-29","kind":"exercise","acquired":true,"shares":5770,"price":0.63,"value":3635.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":9652,"source":{"system":"sec-edgar","filing":"0001638599-17-000668","document":"doc4_4828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000668/doc4_4828.xml","form_type":"4"}},{"id":4269241,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-30T20:33:56.000Z","date":"2017-06-29","kind":"exercise","acquired":true,"shares":3846,"price":0.47,"value":1807.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016."}],"balance_after":3882,"source":{"system":"sec-edgar","filing":"0001638599-17-000668","document":"doc4_4828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000668/doc4_4828.xml","form_type":"4"}},{"id":4271016,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":172994,"kind":"person","name":"Siewers David","position":1,"cik":"0001676906","reported_name":"Siewers David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-28T20:35:14.000Z","date":"2017-06-26","kind":"sale","acquired":false,"shares":6886,"price":20,"value":137720.0,"ownership":{"direct":true},"balance_after":36,"source":{"system":"sec-edgar","filing":"0001638599-17-000660","document":"doc4_4822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000660/doc4_4822.xml","form_type":"4"}}]}